Hughes introduces bill awarding veterans with university credit

first_img Categories: Hughes News 22Jan Hughes introduces bill awarding veterans with university credit State Rep. Holly Hughes, R-Montague, next week will introduce legislation to award university academic credits to veterans who have completed college-level training in their years of military service.“Michigan’s veterans have provided an irreplaceable service to our state and our country,” said Hughes, vice chair of the Committee on Military and Veterans Affairs. “As citizens whose rights are protected by these brave men and women, it is the least we can do to aid their transition back into civilian life.”House Bill 4060 gives veterans the opportunity to use their college-level training gained from military service to apply for academic credits at universities across the state.“Our veterans fought for our freedoms during their service,” she said. “We owe it to them to award these academic credits they so rightly deserve.”Currently, veterans are often required take all classes under a curriculum at colleges and universities, despite possible overlap from their military training. Some colleges and universities already offer credit for military service, but this information is not made readily available to veterans when they enroll.Similar legislation was passed last year giving veterans community college credits for their training, and was designated Public Act 483 of 2014.###Hear more from Rep. Hughes on this legislation:+Rep. Holly Hughes, R-Montague, on university credit for military servicelast_img read more

admin

Video advertising technology specialist YuMe has r

first_imgVideo advertising technology specialist YuMe has received a strategic investment of US$12 million (€9 million) from Samsung’s venture capital arm, Samsung Ventures, and Translink Capital.The company said the funding would be used to aggressively expand its footprint in the connected TV space and fuel its global expansion.YuMe’s system for connected TVs, the Embedded SDK, includes technology that CE manufacturer can use to create a monetisation platform in their devices. The Embedded SDK integrates with YuMe’s flagship technology, ACE for Publishers, and the YuMe Connected Audience Network. ACE for Publishers enables publishers to simplify video ad serving and management functions across connected device channels, according to the company, while the Connected Audience Network is YuMe’s premium in-stream video ad network.last_img read more

admin

Telecom Italia has launched a broadbanddelivered

first_imgTelecom Italia has launched a broadband-delivered subscription video-on-demand service under the Cubovision brand.The service officially launched yesterday and the Italian telco has inked content deals with providers including CBS Studios, which will make a range of programming available via a branded on-demand channel on the service.The programming deal with CBS, which was concluded on a non-exclusive basis, gives streaming service Cubovision a range of US TV series including NCIS, Dexter and 90210. Classic CBS-distributed series including Twin Peaks and Star Trek: Enterprise will also be available on the service.
“With its launch in Italy, Cubovision is focused on adding significant quality to the entertainment choices available to Italian consumers, while providing a valuable new channel, increased consumer reach, adding “value creation” to the entire offer of TV programming from Telecom Italia” said Paolo d’Andrea, head of Innovative VAS, Telecom Italia.last_img read more

admin

Ukrainian cable operator Volia has upgraded its ne

first_imgUkrainian cable operator Volia has upgraded its networks in Zaporizhia in eastern Ukraine, Kirovohrad in central Ukraine and Chernivtsi in the western part of the country, enabling it to offer DOCSIS 3.0-based high-speed internet services in the three cities. Customers in Zaporizhia, Kirovohrad and Chernivtsi will be able to subscribe to 60Mbps and 100Mbps packages as well as a new package of internet bundled with TV services.The company said it would offer free replacement modems to all customer that subscribed to internet packages of 30Mbps or above.last_img

admin

Could we prevent Alzheimers disease by treating herpes

first_imgHow does this work? Itzhaki and her colleagues already demonstrated that HSV1 infection led to the characteristic neuronal plaques and neurofibrillary tangles of Alzheimer’s disease, which supports the epidemiological findings.This was proven by the presence of viral DNA within amyloid plaques in brains of patients with Alzheimer’s disease at postmortem.In addition, in cell cultures infected with HSV1, both amyloid plaques and tau tangles accumulate, but this can be inhibited by the use of antivirals.Preventing Alzheimer’s diseaseDr. Itzhaki stresses that the Taiwanese data apply only to severe infections with HSV1 or VZV, which are atypical.To strengthen their findings, detailed epidemiological data on dementia would need to be drawn from people with mild HSV1 infection (both cold sores and genital herpes). This data is difficult to find, however, with barely any records.The focus of future research will be to verify the observation that HSV1 infection is causally related to Alzheimer’s disease and to define the nature of this link.However, Itzhaki is already looking forward to the exciting prospect of being able to treat this widespread and often disabling condition with antiviral drugs directed against HSV1.Taking inspiration from the global use of human papillomavirus (HPV) immunization to protect against cervical cancer, the research team is hopeful that uncovering this virus-disease link will lead to the effective treatment and prevention of Alzheimer’s disease, by a vaccine against HSV1, for instance. Source:This news story is based on a press release by the journal, Frontiers in Ageing Neuroscience, and the review itself, entitled “Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease” which was published today. By Dr. Liji Thomas, MDOct 19 2018Reviewed by Kate Anderton, B.Sc. (Editor)An exciting new review paper by Professor Ruth Frances Itzhaki suggests that over half of all cases of Alzheimer’s disease could be traced back to Herpes Simplex Virus 1 (HSV1) ; the virus responsible for cold sores and genital herpes.Image Credit: Lightspring / ShutterstockImportantly, the research suggests that the use of antivirals to treat severe herpes virus infection could reduce the risk of senile dementia.The review, which traces Dr. Itzhaki’s lifetime of work on the causation of Alzheimer’s disease, was recently published in the journal, Frontiers in Ageing Neuroscience.If confirmed, this groundbreaking work points to an inexpensive and effective means of preventing Alzheimer’s disease, which is one of the most costly medical conditions in the world.HSV1 underlies Alzheimer’s diseaseHerpes simplex virus 1 (HSV1) is notorious for its tendency to remain dormant in a patient’s neurons and immune system.The infection is reactivated under conditions of weakened immunity or stress. This results in the reappearance of cold sores. Most older adults show the presence of antibodies against HSV1.In older studies, Itzhaki had shown that cold sores are more common in patients who carry the gene variant APOE-ε4, which is also associated with a higher risk of Alzheimer’s disease.She theorizes that Apolipoprotein E-ε4 (ApoE-ε4), which has been strongly linked to Alzheimer’s disease, predisposes the patient to more frequent or damaging reactivations of HSV1 in the neurons of the brain. This causes harmful changes within the neurons to accumulate, resulting in Alzheimer’s disease.Proving the linkIn most countries there simply isn’t enough population data to put the HSV1 theory to the test, since information on the reduction of dementia risk in individuals treated with antivirals, for instance, is not typically collected.Taiwanese scientists have succeeded in accumulating this type of data, however.The National Health Insurance Research Database has over 99.9% of the population on its rolls, and data mining of this vast repository is underway in multiple areas to explore contagious diseases and other conditions.As a result, 2017-18 witnessed the publication of three separate reports on the Taiwanese data relating to the occurrence of senile dementia, caused mainly by Alzheimer’s disease, as well as on the treatment of patients who have frank HSV or VZV (varicella-zoster virus, chickenpox virus) infection. Considering that over 150 publications strongly support an HSV1 role in Alzheimer’s, these Taiwan fndings greatly justify usage of antiherpes antivirals – which are safe and well-tolerated – to treat Alzheimer’s disease. They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.” The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in the number of those subjects severely affected by HSV1 who later develop dementia.”last_img read more

admin

Common medications to treat heartburn linked to increased risks for kidney failure

first_imgReviewed by James Ives, M.Psych. (Editor)Mar 19 2019Common medications prescribed to treat heartburn, acid reflux and ulcers are linked to increased risks for kidney failure and chronic kidney disease, found a recent University at Buffalo study.Use of proton pump inhibitors (PPI), a group of drugs that reduce the production of stomach acid, increases the risk of chronic kidney disease by 20 percent and raises the risk of kidney failure by four times. Risks were highest among people at least 65 years old.The research, published in February in Pharmacotherapy, is one of the first large, long-term studies to examine the effects of PPIs on kidney function. Researchers examined the health data of more than 190,000 patients over a 15-year period.Related StoriesChronic kidney disease patients are excluded from clinical trialsSchwann cells capable of generating protective myelin over nerves finds researchArtificial intelligence can help accurately predict acute kidney injury in burn patients”This study adds to a growing list of concerning side effects and adverse outcomes associated with PPIs,” says David Jacobs, PharmD, PhD, lead investigator and assistant professor of pharmacy practice in the UB School of Pharmacy and Pharmaceutical Sciences.”Given the increasing global use of PPIs, the relationship between PPIs and renal disease could pose a substantial disease and financial burden to the health care system and public health.”PPIs are one of the most commonly prescribed medications in the U.S., with an estimated 113 million prescriptions filled in 2008, costing patients nearly $14 billion, says Jacobs.Due to acid reflux and related conditions only requiring short-term treatment with PPIs, he adds, up to 70 percent of patients overuse these medications without benefit and are subjected to unnecessary adverse effects.The prevalence of PPI use in the U.S. could have a devastating effect on public health. Because these drugs are still considered safe, education and deprescribing initiatives are needed to raise awareness among health care providers, says Jacobs. Deprescribing may involve reducing dosage or stopping usage.Data for the investigation was gathered from medical insurance and prescription claims from a Western New York insurer. Researchers examined medical history from 1993-2008 of adult patients with no history of kidney disease.Kidney health was compared between patients who underwent PPI therapy and those who were unexposed. Examined PPIs included esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole (commonly known by brand names as Vimovo, Prevacid, Prilosec, Protonix and Aciphex, respectively). Source:buffalo.edu/news/releases/2019/03/0220.htmllast_img read more

admin

Savings from lower insurance costs of growth hormone drugs not passed on

first_imgReviewed by James Ives, M.Psych. (Editor)Mar 25 2019Increasingly aggressive insurance strategies have lowered the total costs and insurance costs of growth hormone drugs, but those savings are not being passed on to patients, according to new research to be presented Sunday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.In 2003, the U.S. Food and Drug Administration approved growth hormone treatment for idiopathic short stature (children who are short for no known cause). This expanded potential eligibility for treatment to the shortest 1.2 percent of the U.S. population, at a potential estimated national cost of $40 billion.”However, in subsequent years, health insurance companies imposed greater barriers to reimbursement for growth hormone treatment,” said lead researcher Adda Grimberg, M.D., of the Perelman School of Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania in Philadelphia, Penn. Insurers have instituted formularies–lists of drugs that are covered by the insurance plan–that exclude all but a few brands of growth hormone drugs, and change these lists frequently based on prices negotiated with manufacturers, forcing patients to switch brands during their course of treatment. Insurers have also adopted more stringent criteria for coverage, and many no longer cover growth hormone treatment for idiopathic short stature.Grimberg and her co-author Genevieve P. Kanter, Ph.D., of the University of Pennsylvania, examined how use of growth hormone by U.S. youth changed over time. Using a database of 18 million individuals enrolled in commercial health plans, they examined changes in use and expenditures between 2001 and 2016. They focused on the 38,857 beneficiaries up to age 18 treated with growth hormone who had six or more months of insurance coverage in any year between 2001 and 2016.The number of members with growth hormone prescriptions per 10,000 beneficiaries under age 18 rose steadily from 5.1 in 2001 to 14.6 in 2016, without a dramatic change around 2003, the year the FDA approved coverage for idiopathic short stature. Progressive restrictions on growth hormone coverage imposed by insurers and stricter formulary rules appear to have succeeded in lowering the total cost and insurer cost of treatment. However, those savings were not passed on to patients, who also were forced to switch drug brands as insurance companies changed their formularies.Related StoriesStudy finds increased financial burden for growth hormone treatment despite FDA approvalAdipose hormone levels may be independent risk factor for obesity-related asthmaCould hormone therapy for prostate cancer increase the risk of Alzheimer’s disease?While total growth hormone expenditures per patient decreased by 27 percent and the estimated insurance-paid amount decreased by 28 percent, average copayments, deductibles and total patient financial burden increased by 161 percent. Between 2001 and 2007, beneficiaries switching growth hormone brands at least once in the year ranged from 1.4 percent to 3.6 percent. After 2007, the range rose to 5.1 percent to 8.8 percent, with 25.6 percent switching in 2009 and 13.9 percent switching in 2015.”These patterns are consistent with broader U.S. trends of increased patient cost-sharing and aggressive use of formularies and coverage restrictions to limit insurer costs from high specialty drug prices,” Grimberg said. “The rising patient costs of insulin have emerged as an important health care concern in recent days, prompting Congressional hearings and legislative review. Our research shows that growth hormone, another endocrine medication like insulin, is costing patients more, even as costs to insurers have declined.”Grimberg noted that the patient burden of growth hormone brand switches and insurance denials/appeals is a source of great distress for patient families seeking evaluation and treatment of short stature. “Because the different growth hormone brands are delivered in different pen devices, insurance-mandated brand switches during the years a patient is treated with growth hormone require retraining on proper administration, so the process is more complicated than simply switching from one pill to another,” she said.Source: https://www.endocrine.org/last_img read more

admin

US military investing 2 bn in next generation artificial intelligence

first_img Explore further This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. The Pentagon’s research wing said Friday it was investing $2 billion to develop a new generation of artificial intelligence with “human-like communication” skills. A military robot deployed with NATO troops in Latvia is inspected by Canadian Prime Minister Justin Trudeau in July 2018. Citation: US military investing $2 bn in ‘next generation’ artificial intelligence (2018, September 7) retrieved 17 July 2019 from https://phys.org/news/2018-09-military-investing-bn-artificial-intelligence.htmlcenter_img The Defense Advanced Research Projects Agency, or DARPA, will use the money to fund around 20 existing projects over the next five years and launch new ones over the next 12 months seeking a higher level of machine learning, the agency’s director Steven Walker told reporters near Washington.”We are making multiple research investments aimed at transforming computers from specialized tools to partners in problem-solving,” said Walker, referring to the new generation of machines as “AI Next.””We want to explore how machines can acquire human-like communication and reasoning capabilities, with the ability to recognize new situations and environments and adapt to them,” he said in a statement.The current generation of smart machines and robots cannot be easily updated when new technology appears, and researchers want them to learn to update themselves, he said.The new smart machines will be designed to help speed up security clearance vetting or accelerated accreditation of software systems, the agency said. Most of DARPA’s research, which is entirely funded by the Pentagon, is focused on technologies that can be used in combat, such as drones that are becoming ever more autonomous.Another use could be DARPA’s Blackjack project, which aims to develop a constellation of low-orbit satellites that will communicate with one another and can continuously cover military operations.”We will be looking at, under that program, to help satellites be able to communicate and develop a corporate behavior,” Walker said. AI has already been weaponised – and it shows why we should ban ‘killer robots’ © 2018 AFPlast_img read more

admin

Tesla shares bounce as Musk risk seen as overblown

first_imgElon Musk is ‘not your typical CEO,’ ana analyst said, but Tesla is on track to meet manufacturing targets which could boost the share price Alliance Bernstein analyst Toni Sacconaghi, Jr. said much of the pressure on Tesla shares over the last month has been due to the sense Musk is “running wild and can’t be contained” following a patch of erratic behavior, including a podcast appearance Thursday night in which he smoked marijuana.”Musk is not your typical CEO,” Sacconaghi wrote. “As long as he doesn’t self-destruct, we think this is the reality (show) of being a Tesla investor.”But, he said, “if Elon and the Board wisely choose to add an executive/’adult in the room’ and manage to restrict his twitter/public commentary, it would likely be viewed positively.”Near 1915 GMT, Tesla shares were up 6.5 percent to $280.22, recovering from Friday’s selloff prompted by the news of two executive departures and criticism of Musk’s pot-smoking podcast appearance.The gains also came after Musk himself said in an email to employees late Friday that the company was on track for the “most amazing quarter in our history” and urged employees to ignore “fuss and noise” about the company in the media.The note said a US securities probe following Musk’s brief flirtation with taking the electric car maker private was unlikely to have an impact, although the frequent turnover of senior Tesla executives was more concerning.But Sacconaghi said the company remained on track to meet key car manufacturing targets in the third quarter and predicted shares would return to their historic range as the aborted go-private campaign becomes a more distant memory.”We see relatively little downside risk from fundamentals in the near-term, especially given somber expectations,” the note said. Tesla shares bounced Monday following an upbeat analyst note that suggested worries about chief executive Elon Musk and his various controversies were exaggerated. © 2018 AFP Tesla’s top accountant exits after a month on the jobcenter_img This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Explore further Citation: Tesla shares bounce as Musk risk seen as overblown (2018, September 10) retrieved 17 July 2019 from https://phys.org/news/2018-09-tesla-musk-overblown.htmllast_img read more

admin

Beyond Meat raises 241 mn amid growing appetite for vegan food

first_imgBeyond Meat has tapped into changing consumer appetites as growing numbers of people turn to plant-based meat alternatives Vegan burger upstart Beyond Meat, whose backers include Hollywood star Leonardo DiCaprio and Microsoft founder Bill Gates, has raised $241 million from its initial public offering, valuing the firm at about $1.5 billion as it surfs a wave of flexitarianism. “We have a history of losses, and we may be unable to achieve or sustain profitability,” the firm cautioned in its filing with the Securities and Exchange Commission.The group said it would use the funds raised to “expand our marketing channels, invest in our distribution and manufacturing facilities, hire additional employees and enhance our technology and production capabilities.”Like fellow “veggie burger” maker Impossible Foods, Beyond Meat uses sophisticated technologies to replicate as closely as possible the taste, color, smell and texture of meat.It uses peas, beans and soy to make steaks and sausages or replace minced meat in tacos and spaghetti bolognese. The firm’s popular Beyond Burger, which uses beets to make it ‘bleed’, is sold in thousands of supermarkets and restaurants, including TGI Fridays.Beyond’s rival Impossible, meanwhile, has linked up with Burger King to offer a vegan version of its signature Whopper. Nestle and Unilever are also aiming to expand their presence in the expanding sector.Beside Gates and DiCaprio, its early backers include Twitter co-founders Biz Stone and Evan Williams, former McDonald’s director Don Thompson, meat giant Tyson Foods and the Humane Society. The California-based firm said it sold 9.625 million shares on the Nasdaq exchange at $25 each on Wednesday, at the top of its offer range. Reflecting strong investor demand, it had increased the offer price of its shares to $23-25 from $19-21.The company has tapped into changing consumer appetites as growing numbers of people turn to plant-based meat alternatives, whether vegans who shun all animal products or flexitarians, who advocate moderate consumption of meat.”We believe that consumer awareness of the perceived negative health, environmental and animal-welfare impacts of animal-based meat consumption has resulted in a surge in demand for viable plant-based protein alternatives,” it said in its prospectus.The firm said it believed eating plant-based protein would “help address concerns related to human health, climate change, resource conservation and animal welfare” as it seeks to compete with the $1.4 trillion global meat industry.Despite the popularity of its signature Beyond Burger and other products, Beyond Meat is still not profitable and recorded a net loss of $30 million in 2018, according to its most recent financial records released Monday.But it has seen strong growth, with $88 million in sales in 2018, compared with $33 million in 2017 and $16 million in 2016. This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. © 2019 AFPcenter_img Beyond Meat’s backers include Hollywood superstar Leonardo DiCaprio Explore further Citation: Beyond Meat raises $241 mn amid growing appetite for vegan food (2019, May 2) retrieved 17 July 2019 from https://phys.org/news/2019-05-meat-mn-appetite-vegan-food.html Burger King goes… vegan? The meatless Whopper is herelast_img read more

admin

Oltmans Show me you can after McCann stint

first_img Related News Hockey 03 Jul 2019 Hockey team are on the rise, says Oltmans Related News Hockey 07 Jul 2019 Firdaus on the verge of gaininghis first cap KUALA LUMPUR: Show us what you’ve got.The national hockey strikers had a one-week training session with former Australian ace striker Michael McCann and coach Roelant Oltmans wants them to translate what they have learned in the playing tour of Europe.“I want to see them sharper and more clinical in their finishing. This is what I hope for in the nine matches there.“The tour is important as we want to prove to the Europeans that we are a competitive team and not to be taken lightly. {{category}} {{time}} {{title}} Hockey 25 Jun 2019 Oltmans calls up sabahan to solve Malaysia’s goalkeeping woes “The stint is also our preparation for the playoff matches (October and November) to qualify for the Olympic Games,” said the Dutchman.He added that it would be good for the players to compete against world champions Belgium, Germany, Holland and England.“It will give us the chance to further improve on our game structure in preparation for the playoffs. “We need to keep improving as our goal is to qualify for the Olympics,” added Oltmans.Malaysia will also play in a four-nation event against hosts Spain, Ireland and England.Twenty players have been named for the three-week tour with goalkeeper Adrian Andy Albert and forward Muhd Noor Firdaus Rosdi making their international debut.Oltmans said that all 30 players in the training squad would be given a chance to play as they want to pick the best for the playoffs.“Those who are not in the playing tour of Europe will play in a four-nation tournament in Tokyo (August) and also the five-match playing tour of South Korea (September).” Roelant Oltmanslast_img read more

admin

Supreme Court orders commencement of work for Phase 4 of Delhi Metro

first_img Press Trust of India New DelhiJuly 12, 2019UPDATED: July 12, 2019 15:44 IST The EPCA report said that there was a “stalemate” in discussions between the central government and Delhi government on certain financial aspects of the project. (File Photo)The Supreme Court Friday ordered implementation of the 103.94 km, Phase 4 of the Delhi metro and directed the authorities concerned to commence construction work on the project.A bench comprising Justices Arun Mishra and Deepak Gupta was told by the counsel appearing for the Delhi government that they have agreed to give a go ahead to the Phase 4 of the Delhi metro.The apex court was hearing a matter in which the Environment Pollution Control Authority (EPCA) had recently filed a report stating that the approval for the project was held up since 2014.The EPCA report said that there was a “stalemate” in discussions between the central government and Delhi government on certain financial aspects of the project.”There is a stalemate in the discussions between the Union Government and the Delhi government on different financial aspects of the project. The Delhi government has on April 10, 2019 communicated its direction that DMRC (Delhi Metro Rail Corporation) would not start work of Delhi Metro phase-IV till these issues are resolved,” it said.The stalemate came under the apex court’s scanner which said it would pass order in the matter as the “project cannot wait”.The court was also told by the apex court that the project was “critical” and the pending issue should be resolved soon.The Centre had told the court that project financing has been done in consonance with the Metro Rail Policy of August 2017 and metro projects of other cities like Bhopal, Indore, Kanpur, Patna and Agra have been sanctioned on the same financial pattern as of Delhi metro phase-IV.The EPCA report had said that the project is “critical as it will add another 104 km to the network” and “it is designed to join the current network and will densify it and make the system more viable and attractive to commuters”.ALSO READ | Delhi Metro snag: Thousands stranded, traffic chokes Delhi-Gurgaon highway as Yellow Line collapsesALSO WATCH | Arvind Kejriwal announces free travel for women in Delhi Metro, busesFor the latest World Cup news, live scores and fixtures for World Cup 2019, log on to indiatoday.in/sports. Like us on Facebook or follow us on Twitter for World Cup news, scores and updates.Get real-time alerts and all the news on your phone with the all-new India Today app. Download from Post your comment Do You Like This Story? Awesome! Now share the story Too bad. Tell us what you didn’t like in the comments Posted bySnigdha Choudhury Supreme Court orders commencement of work for Phase 4 of Delhi MetroA bench comprising Justices Arun Mishra and Deepak Gupta was told by the counsel appearing for the Delhi government that they have agreed to give a go ahead to the Phase 4 of the Delhi metro. The apex court was hearing a matter in which the Environment Pollution Control Authority (EPCA) had recently filed a report stating that the approval for the project was held up since 2014.advertisement Nextlast_img read more

admin

13004 pilgrims pay obeisance at Amarnath cave shrine

first_img Press Trust of India SrinagarJuly 12, 2019UPDATED: July 12, 2019 22:10 IST Till date, 1,57,062 yatris have had the darshan of the Shivling. (Image used for representation)A total of 13,004 pilgrims paid obeisance at the naturally formed ice lingam in the cave shrine of Amarnath on Friday, officials said.With this, the number of pilgrims who have visited the shrine in south Kashmir Himalayas has crossed 1.5 lakh, they said.”On the 12th day of the ongoing Shri Amarnathji Yatra, 13,004 yatris paid obeisance at the holy cave. Till date, 1,57,062 yatris have had the darshan of the Shivling,” a spokesperson of the Shri Amarnath Ji Shrine Board said.The annual Amarnath pilgrimage commenced on July 1 and will conclude on August 15, coinciding with the festival of Raksha Bandhan.Also Read | Jammu Darshan bus service launched in J&K to promote tourismAlso Read | Over 1.44 lakh pilgrims perform Amarnath Yatra in 11 daysAlso Watch | First batch of Amarnath pilgrims reaches shrineFor the latest World Cup news, live scores and fixtures for World Cup 2019, log on to indiatoday.in/sports. Like us on Facebook or follow us on Twitter for World Cup news, scores and updates.Get real-time alerts and all the news on your phone with the all-new India Today app. Download from Post your comment Do You Like This Story? Awesome! Now share the story Too bad. Tell us what you didn’t like in the comments Posted byChanchal Chauhan 13,004 pilgrims pay obeisance at Amarnath cave shrineWith this, the number of pilgrims who have visited the shrine in south Kashmir Himalayas has crossed 1.5 lakh.advertisement Nextlast_img read more

admin